Circulating miRNA expression in long-standing type 1 diabetes mellitus

Area of Science:

• Endocrinology
• Molecular Biology
• Cardiovascular Research

Background:

• Type 1 diabetes (T1D) is an autoimmune disease causing glucose dysregulation and vascular complications.
• MicroRNAs (miRNAs) are implicated in T1D pathogenesis and associated comorbidities.
• Identifying novel biomarkers for T1D vascular complications is crucial.

Purpose of the Study:

• To analyze the circulating miRNA expression profile in patients with type 1 diabetes.
• To identify specific miRNAs associated with T1D and potential vascular risks.
• To explore the functional pathways targeted by identified miRNAs.

Main Methods:

• Plasma samples from 85 individuals (T1D patients and controls) were analyzed.
• Next-generation sequencing identified differentially expressed miRNAs.
• Taqman RT-PCR validated miRNA expression levels.
• Bioinformatic analysis investigated target gene pathways.

Main Results:

• hsa-miR-1-3p expression was significantly increased in T1D patients compared to controls.
• Elevated hsa-miR-1-3p levels correlated positively with glycated hemoglobin (HbA1c).
• Bioinformatic analysis revealed hsa-miR-1-3p targets genes involved in vascular development and cardiovascular diseases.

Conclusions:

• Circulating hsa-miR-1-3p is a potential prognostic biomarker for T1D.
• hsa-miR-1-3p may help predict and prevent vascular complications in T1D patients.
• Combined monitoring of hsa-miR-1-3p and glycemic control could improve T1D management.